PALS

10 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Scopoderm® patches arm	Revance Therapeutics, Inc. (RVNC)

Phase 2(4)

Drug	Company
ARV-102	ARVINAS, INC. (ARVN)
Conditioned Medium	Accustem Sciences Inc. (ACUT)
GV1001 0.56mg	Cidara Therapeutics, Inc. (CDTX)
GV1001 1.12mg	Cidara Therapeutics, Inc. (CDTX)

Phase 1(1)

Drug	Company
Umbilical Cord Mesenchymal Stem Cells	Accustem Sciences Inc. (ACUT)

Phase 4(4)

Drug	Company
Botox® injection	Revance Therapeutics, Inc. (RVNC)
Control	Revance Therapeutics, Inc. (RVNC)
onabotulinumtoxin A	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 10 drugs in development for PALS across 4 companies.

There are 1 clinical trial targeting PALS tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.